 |
市场调查报告书
商品编码
1573921
治疗计划系统和先进影像处理市场、机会、成长动力、产业趋势分析和预测，2024-2032 年Treatment Planning Systems and Advanced Image Processing Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
||||||
2023 年，全球治疗计划系统和先进影像处理市场价值约为 20 亿美元，预计 2024 年至 2032 年复合年增长率为 8.6%。处理使用复杂的演算法增强、分析和解释医学影像。癌症发病率的上升和医学影像程序的增加正在推动对治疗计划系统的需求，从而促进市场成长。使用先进影像处理技术进行精确肿瘤治疗的需求也推动了全球市场的扩张。
整体治疗计划系统和先进影像处理行业根据组件、应用、技术、最终用户和地区进行分类。
按组成部分细分市场，治疗计划系统在 2023 年带来了 13 亿美元的收入。人们对治疗计划软体（尤其是放射治疗）优势的认识进一步推动了该细分市场的成长。医疗保健基础设施的进步、公私合作伙伴关係以及向软体解决方案而非传统方法的转变也推动了市场扩张。例如，2021年2月，富士通有限公司与多伦多大学合作，优化脑肿瘤和动静脉畸形的放射治疗计画。
按应用划分，肿瘤学领域在 2023 年处于领先地位，收入为 9.948 亿美元，预计复合年增长率为 8.8%。全球癌症病例激增推动了对先进肿瘤治疗计划系统的需求。成像技术的创新，特别是人工智慧驱动的影像处理和机器学习演算法，提高了治疗计划的准确性和效率，推动了市场成长。人们对各种癌症的放射治疗的偏好不断增加，这增加了对先进治疗计划软体、优化放射剂量和最大限度减少副作用的需求。
在该地区强大的医疗基础设施的推动下，北美治疗计画系统和先进影像处理市场预计到 2032 年将达到 19 亿美元。 2023年，美国以8.222亿美元的收入领先北美市场。美国市场的发展势头得益于不同年龄层癌症发病率的上升以及对先进治疗计划工具和成像技术的需求不断增加。美国国家癌症研究所 2022 年 1 月的数据显示，美国约有 1,810 万名癌症倖存者，突显了癌症管理领域对创新医疗解决方案的迫切需求。
目录
第 1 章：方法与范围
第 2 章：执行摘要
第 3 章：产业洞察
- 产业生态系统分析
- 产业影响力
- 成长动力
- 癌症盛行率上升
- 影像和治疗技术的持续创新
- 转向个人化治疗
- 产业陷阱与挑战
- 与取得和维护先进治疗计划系统相关的巨额成本
- 严格的监管要求和漫长的审批流程
- 成长动力
- 成长潜力分析
- 未来市场趋势
- 监管环境
- 技术景观
- 波特的分析
- PESTEL分析
第 4 章：竞争格局
- 介绍
- 公司市占率分析
- 公司矩阵分析
- 主要市场参与者的竞争分析
- 竞争定位矩阵
- 战略仪表板
第 5 章：市场估计与预测：按组成部分，2021 - 2032 年
- 主要趋势
- 先进的影像处理系统
- 治疗计划系统
第 6 章：市场估计与预测：按应用分类，2021 - 2032
- 主要趋势
- 肿瘤学
- 心臟病学
- 神经病学
- 骨科
- 其他应用
第 7 章：市场估计与预测：按技术分类，2021 - 2032
- 主要趋势
- 基于 MRI 的规划
- 基于 CT 的规划
- 放射治疗
- 3D适形放射治疗
- 调强放射治疗
- 影像导引放射治疗
- 立体定位放射治疗
- 质子束治疗
第 8 章：市场估计与预测：按最终用途，2021 - 2032 年
- 主要趋势
- 医院
- 门诊手术中心
- 专科诊所
- 其他最终用户
第 9 章：市场估计与预测：按地区划分，2021 - 2032 年
- 主要趋势
- 北美洲
- 我们
- 加拿大
- 欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
- 中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
第 10 章：公司简介
- Accuray Incorporated
- Agfa-Gevaert Group
- Brainlab AG
- Canon Medical Systems Corporation
- C-RAD AB
- Elekta AB
- GE HealthCare Technologies Inc.
- Hitachi, Ltd.
- IBA Radiopharma Solutions
- IntraOp Medical Corporation
- Koninklijke Philips N.V.
- Mercurius Health
- Mirada Medical Limited
- Siemens Healthineers AG
- ViewRay, Inc.
The Global Treatment Planning Systems and Advanced Image Processing Market was valued at approximately USD 2 billion in 2023 and is projected to indicate a growth rate of 8.6% CAGR from 2024 to 2032. Treatment planning systems craft precise treatment plans for radiation therapy patients, while advanced image processing enhances, analyzes, and interprets medical images using sophisticated algorithms. The rising incidence of cancer and an increase in medical imaging procedures are driving demand for treatment planning systems, boosting market growth. The global market's expansion is also driven by the need for precise oncology treatments using advanced image processing technology.
The overall treatment planning systems and advanced image processing industry are classified based on the component, application, technology, end-user, and region.
Segmenting the market by component, treatment planning systems led to a revenue of USD 1.3 billion in 2023. This segment's dominance is due to the escalating cancer prevalence and the growing demand for precise oncology therapy solutions. Awareness of the benefits of treatment planning software, especially in radiotherapy, further fuels this segment's growth. Advancements in healthcare infrastructure, public-private partnerships, and a shift towards software solutions over traditional methods also drive market expansion. For instance, in February 2021, Fujitsu Limited collaborated with the University of Toronto to optimize radiation treatment plans for brain tumors and arteriovenous malformations.
By application, the oncology segment led in 2023 with a revenue of USD 994.8 million and is projected to grow at a CAGR of 8.8%. The global surge in cancer cases drives demand for advanced oncology treatment planning systems. Innovations in imaging technologies, particularly AI-driven image processing and machine learning algorithms, enhance treatment planning accuracy and efficiency, propelling market growth. The rising preference for radiotherapy for various cancers has increased demand for advanced treatment planning software, optimizing radiation dosage and minimizing side effects.
The North American market for treatment planning systems and advanced image processing is forecasted to reach USD 1.9 billion by 2032, driven by the region's robust healthcare infrastructure. In 2023, the U.S. led the North American market with a revenue of USD 822.2 million. The U.S. market's momentum is fueled by a rising cancer incidence across diverse age groups and an increasing demand for advanced treatment planning tools and imaging technologies. Data from the National Cancer Institute in January 2022 highlighted about 18.1 million cancer survivors in the U.S., underscoring the pressing demand for innovative healthcare solutions in cancer management.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising prevalence of cancer
- 3.2.1.2 Continuous innovations in imaging and treatment technologies
- 3.2.1.3 Shift towards personalized treatment
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Significant costs associated with acquiring and maintaining advanced treatment planning systems
- 3.2.2.2 Stringent regulatory requirements and lengthy approval processes
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Future market trends
- 3.5 Regulatory landscape
- 3.6 Technological landscape
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Advanced image processing systems
- 5.3 Treatment planning systems
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Oncology
- 6.3 Cardiology
- 6.4 Neurology
- 6.5 Orthopedics
- 6.6 Other applications
Chapter 7 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 MRI-based planning
- 7.3 CT-based planning
- 7.4 Radiation therapy
- 7.4.1 3D conformal radiation therapy
- 7.4.2 Intensity-modulated radiation therapy
- 7.4.3 Image-guided radiation therapy
- 7.4.4 Stereotactic body radiation therapy
- 7.5 Proton beam therapy
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Hospitals
- 8.3 Ambulatory surgical centers
- 8.4 Specialty clinics
- 8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 Accuray Incorporated
- 10.2 Agfa-Gevaert Group
- 10.3 Brainlab AG
- 10.4 Canon Medical Systems Corporation
- 10.5 C-RAD AB
- 10.6 Elekta AB
- 10.7 GE HealthCare Technologies Inc.
- 10.8 Hitachi, Ltd.
- 10.9 IBA Radiopharma Solutions
- 10.10 IntraOp Medical Corporation
- 10.11 Koninklijke Philips N.V.
- 10.12 Mercurius Health
- 10.13 Mirada Medical Limited
- 10.14 Siemens Healthineers AG
- 10.15 ViewRay, Inc.
